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a b s t r a c t
pain is a disabling symptom and is often the foremost symptom of conditions for which patients undergo neurorehabilitation. We systematically 
searched the pubMed and Embase electronic databases for current evidence on the frequency, evolution, predictors, assessment, and pharmaco-
logical and non-pharmacological treatment of pain in patients with headache, craniofacial pain, low back pain, failed back surgery syndrome, 
osteoarticular pain, myofascial pain syndrome, fibromyalgia, and chronic pelvic pain. Despite the heterogeneity of published data, consensus 
was reached on pain assessment and management of patients with these conditions and on the utility of a multidisciplinary approach to pain 
therapy that combines the benefits of pharmacological therapy, physiotherapy, neurorehabilitation, and psychotherapy. We of the Italian Consen-
sus Conference on Pain in Neurorehabilitation (ICCPN) suggest a need to conduct randomized controlled trials on the efficacy of pain treatments 
and their risk-benefit profile for the conditions we have reviewed.
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ability, and medical care costs or indemnity payment. 
because different pathophysiologic mechanisms, as 
well as different types of pain may co-occur in the same 
patient, it is important to identify and treat them with 
pharmacological and non-pharmacological therapies 
in a multidisciplinary approach to reduce pain and im-
prove disability.
OP
op frequently diminishes quality of life (Qol) and 
functional profile in patients with neurological diseases. 
secondary op in neurological disorders may lead to re-
duced or increased muscular activity, altered motor con-
trol, use of orthoses or rehabilitation devices, as well as 
overuse of unaffected limbs.
MPS and FM
Mps is characterized by acute or chronic region-
al muscle pain in single or multiple regions (trigger 
points) within taut muscle bands. Mps manifests with 
stiffness and local twitch response when stimulated by 
digital pressure or located needling and generates local 
or referred pain.1 fM is a central pain disorder that aris-
es from a dysfunctional pain modulation system char-
acterized by widespread tenderness often accompanied 
by sleep disturbance, fatigue, cognitive dysfunction, 
dysesthesia, irritable bowel, and mood disturbances. 
recent evidence suggests that peripheral nerve involve-
ment may coexist in some patients.2, 3 fM is comorbid 
with other somatic symptom disorders, associated with 
psychological illness, and strongly influenced by social 
factors.4
CPP
cpp is a complex syndrome that comprises different 
pathological conditions with different treatment strate-
gies. It is defined as non-cyclic pain lasting more than 6 
months, apparently originating from the pelvic area and 
perceived as a sensory and emotional experience. it af-
fects 15-20% of women of reproductive age. cpp is dif-
ficult to identify and treat, making its management often 
frustrating both for patients and clinicians. due to its 
difficult diagnosis, it is the reason for 20% of diagnostic 
laparoscopies and 12-16% of hysterectomies, which in-
pain is a disabling symptom that is often the foremost symptom of conditions for which patients undergo 
neurorehabilitation. This is further confirmed by the In-
ternational Classification of Functioning, Disability and 
health (icf) that includes pain in some categories as 
to body functions (code b280-sensation of pain; code 
b289-sensation of pain, other specified and unspecified; 
code b298-sensory functions and pain, other specified; 
code b299-sensory functions and pain, unspecified).
consistent with the aims of the italian consensus 
conference on pain in Neurorehabilitation (iccpN), 
this article reports current evidence and criteria for good 
clinical practice in pain epidemiology, impact, evalua-
tion, prognosis and treatment for the following clini-
cal conditions: headache and craniofacial pain (cfp), 
low back pain (lbp) and failed back surgery syndrome 
(fbss), osteoarticular pain (op), myofascial pain syn-
drome (MPS) and fibromyalgia (FM), and chronic pel-
vic pain (cpp). While only some of these conditions 
are treated in neurorehabilitation, because of their epi-
demiological impact, they are frequent comorbidities in 
patients with neurological diseases.
CFP
primary headache (ph) accounts for the majority of 
headache complaints in young people and adults; there-
fore, it should be evaluated in non-aged patients under-
going rehabilitation and in all patients undergoing reha-
bilitation for conditions that may cause secondary cfp. 
appropriate assessment of the pain component of the 
disease, as well as co-existing ph, may aid in improv-
ing a patient’s psychophysical well-being, promote ad-
herence to the neurorehabilitation program, and poten-
tially enhance treatment outcome. indeed, rehabilitation 
outcome may be limited by the psychological disorders 
(i.e., anxiety and/or depression) that are often associat-
ed with pain and that will need to be assessed. although 
chronic pain syndromes in any patient should be evalu-
ated to relieve possible sources of suffering, complaints 
not strictly related to the condition for which the patient 
is under therapy are often neglected.
LBP and FBSS
LBP and FBSS carry a significant socioeconomic 
burden in terms of loss of productivity, prolonged dis-
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bilitation, shoulder pain, central nervous diseases; Mps 
and fM: Mps, myofascial pain treatment, myofascial 
pain diagnosis, myofascial pain therapy, myofascial 
pain exercise, fibromyalgia, fibromyalgia syndrome, fi-
bromyalgia pain, fibromyalgia diagnosis, fibromyalgia 
treatment, fibromyalgia therapy, fibromyalgia exercise; 
cpp: interstitial cystitis, endometriosis, irritable bowel 
syndrome, vulvodynia. the search was updated to 2015 
and selected papers were added to the review. in those 
fields with few good quality clinical studies, we chose a 
mixed approach, namely, a review of published studies 
identified through searching the PubMed and Embase 
databases, the grey literature, and a consensus confer-
ence to obtain recommendations from clinical evidence 
and expert opinion.
Results and recommendations
Question 7.1. Which are the classification criteria for 
headache, craniofacial pain, low back pain, osteo-
articular pain, myofascial pain, fibromyalgia, and 
chronic pelvic pain, and what is the epidemiological 
impact of these conditions in neurorehabilitation?
HeadacHe and cFP
We recommend reference to the international head-
ache society diagnostic guidelines, which represent the 
gold standard for classifying headache and craniofacial 
pain subtypes.8, 9
LBP and FBSS
LBP is defined as pain originating from the lower 
margin of the twelfth ribs to the lower gluteal folds; it is 
classified as acute (<4 weeks), sub-acute (4 weeks to 3 
months) or chronic (>3 months). although lbp etiology 
is known in only 5-15% of cases, different pathophysi-
ologic mechanisms may coexist, leading to inflamma-
tory-nociceptive, neuropathic or central-dysfunctional 
pain.10 chronic lbp should be considered a mixed pain 
syndrome involving both nociceptive and neuropathic 
mechanisms. Nociceptive pain may be identified in 50-
70% of lbp patients; the causes include lumbar inter-
vertebral disc impairment, facet or sacroiliac joint dis-
ease, ligament injury or muscle tear. Neuropathic pain 
is present in 5-15% of lbp cases. it usually results from 
compressive or non-compressive lumbar radiculopathy, 
cur considerable medical costs.5 the prevalence of cpp 
is 38/1000 in women aged between 16 and 73 years, 
similar to the rates for asthma (37/1000) or chronic lbp 
(41/1000).6 cpp is more common in persons between 
26 and 30 years of age. No difference in demographic 
characteristics was found between cpp patients and 
controls.
Materials and methods
the methodology of the iccpN was based on the 
italian guidelines for organizing a consensus confer-
ence, the italian guidelines on stroke (stroke prevention 
and Educational awareness diffusion) and the consen-
sus conference on neuropsychological rehabilitation in 
adult patients.7 the iccpN task force was composed of 
a promoter committee, a technical-scientific committee 
and a jury.7 the topics of the iccpN were divided into 
27 working groups, which were incorporated into seven 
main paragraphs, three of which dealt with general is-
sues and the remaining four dealt with specific clinical 
conditions that may be encountered in the neuroreha-
bilitation setting.7 the strength of recommendations 
was scored according to a scale ranging from a to good 
practice point (Gpp) and is reported in parentheses after 
each recommendation.7 for each condition mentioned 
above, we systematically searched the pubMed and 
Embase electronic databases using the following key-
words, their corresponding Mesh terms (when avail-
able), and all their possible combinations for original 
research studies published from 1983 to 2013. head-
ache and cfp: primary headaches, tension-type head-
ache, migraine, orofacial pain, facial pain, facial neural-
gia, trigeminal neuralgia, temporomandibular disorder, 
pain measure, rehabilitation, neurorehabilitation, phar-
macological treatment, non-pharmacological treatment, 
psychotherapy, relaxation therapy, manual therapy, 
physical therapy, osteopathic manipulative treatment, 
chiropractic treatment, orthodontic treatment, phys-
iotherapy, acupuncture, surgical therapy, neuroabla-
tive therapy, local therapy, anesthetic block, herbal 
extracts, botulinum toxin, guidelines; lbp and fbss: 
lbp, fbss, diagnosis and examination, cost of illness, 
epidemiology, pain, nociceptive pain, neuropathic pain, 
myofascial syndrome, visual analogue scale, neuropath-
ic pain diagnostic questionnaire, pain therapy, analgesic 
drugs, rehabilitation; op: musculoskeletal pain, reha-
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associated with stroke, sci, and multiple sclerosis are 
discussed in more detail in another iccpN article,24 to 
which we refer the interested reader.
MPS and FM
it is reported that 15% of routine medical clinic vis-
its and 85% of pain clinic consultations are for soft tis-
sue pain.25 the prevalence of Mps in patients with re-
gional pain ranges from 30 to 93%. the muscles most 
frequently affected by Mps are the trapezius, levator 
scapulae, infraspinatus, and scalene muscles.1 the best 
estimate for the incidence of fM is 2 to 4% in any popu-
lation, regardless of country of origin.3
cPP
urological, gynecological, gastrointestinal, muscu-
loskeletal, and neurological causes may contribute to 
leading to sciatic pain or neurogenic claudicatio. dys-
functional pain is reported to occur mostly in chronic 
lbp with/without other pain syndromes, such as fM 
or chronic widespread pain, and changes in pain per-
ception or body schema. finally, a small percentage of 
patients (one out of thousands) report pain secondary to 
gastrointestinal, kidney or aortic diseases.11
fbss refers to a broad spectrum of conditions char-
acterized by persistent or recurrent lbp, with or without 
sciatic pain, as a result of one or more spinal surgery 
procedures. different types of pain can coexist, leading 
to mixed pain syndrome also in fbss. the radicular 
component may be secondary to inadequate surgical 
decompression, persistent foramen stenosis, epidural 
fibrosis or recurrent disc herniation.12 it has been sug-
gested that if pain appears acutely after surgery, the 
cause may be due to nerve root damage, while pain lo-
calized to the lumbosacral region is more indicative of 
nociceptive causes.12
We refer interested readers to an iccpN paper on the 
clinical and instrumental tools for distinguishing the 
nociceptive and neuropathic components of mixed pain 
conditions.13
OP
op is the leading complaint in several orthopedic, 
rheumatologic, and internal medicine conditions. here 
we will focus on common neurological conditions. op 
may be one of the many complications of acute phase 
stroke.14 shoulder pain on the paretic side, associated with 
complex regional pain syndrome (crps) and knee pain 
on either the affected or the unaffected side are frequent 
in stroke patients.15-17 the op prevalence in parkinson’s 
disease is 46%; the most frequent forms are lbp, espe-
cially in patients with pisa syndrome, shoulder pain and 
knee pain.18 spinal fractures secondary to osteoporosis 
may occur in parkinson’s disease, and therefore should 
be considered in patients with acute back pain.19 op 
may affect over 50% of patients with spinal cord injury 
(sci),20 with shoulder pain related to arthrosis and over-
use syndromes being reported as the main op type.21, 22 
lbp is also common in sci patients, but it frequently 
has a neuropathic component.More than 50% of multiple 
sclerosis patients have pain, but there is a scant literature 
about op in this condition, with lbp prevalence reported 
to range from 10 to 16%.23, 24 the different types of pain 
TaBLe I.—The terminology of chronic pelvic pain.
term Definition
Vulvodynia Vulval discomfort, often described as burning pain, 
with no visible findings, or a specific, clinically 
identifiable neurological disorder
Vestibulodynia provoked pain localized to the vestibule region, 
with pain experienced on sexual and non-sexual 
touch
dyspareunia pain during sexual intercourse at the point of 
penetration or deep in the vagina
(dysaesthetic) 
penoscrotodynia
the male counterpart of vulvodynia, i.e., pain or 
discomfort involving the penis and/or the scrotum
red scrotum 
syndrome
localized painful reddening of the scrotum (similar 
to focal erythromelalgia?)
Vaginismus Tightening of the pelvic floor muscles
pelvic muscles 
hyperactivity
Pathological hyperactivity of pelvic floor muscles
overactive bladder urgency, with or without urge incontinence, and 
daytime and/or night-time frequency, with no 
obvious infection or pathology
interstitial cystitis/
bladder pain 
syndrome
Suprapubic pain related to bladder filling with other 
symptoms (e.g., increased daytime and night-time 
frequency) with no proven urinary infection or 
other obvious pathology
chronic prostatitis/
chronic pelvic 
pain syndrome
Genitourinary pain with or without voiding 
symptoms in the absence of urinary infection or 
other identifiable causes
persistent genital 
arousal disorder
involuntary genital and clitoral arousal that: 1) 
persists for an extended period of time; 2) does 
not go away following one or more orgasms; 
3) is unrelated to subjective feelings of sexual 
desire; 4) is reported as intrusive, unwanted, or 
distressing
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LBP and FBSS
the etiology of lbp is multifactorial, and its diagnosis 
is made by exclusion of other conditions.33 Guidelines 
suggest evaluating the patient’s medical history and 
physical examination to identify the underlying causes of 
lbp, the presence of neurological symptoms and signs, 
and the so-called red flags, which include signs, symp-
toms or risk factors that suggest the presence of a severe 
disease, such as tumor, fracture, infection, spinal cord ste-
nosis, abdominal aortic aneurysm. in patients with acute 
lbp, neuroimaging should be performed only when red 
flags and/or neurologic symptoms and signs are present. 
unexplained persistence of lbp>2-3 months is another 
red flag that should prompt investigation of pain etiol-
ogy. Yellow flags are risk factors for LBP chronicization 
and long-term disability; they include psychological (i.e., 
fear avoidance behavior, unrealistic treatment expecta-
tions, mood disturbances), and social/environmental fac-
tors (i.e., poor job satisfaction, conflicting relationships at 
work, insurance issues).34 lbp intensity is measured with 
generic scales commonly used for evaluating other types 
of pain, such as the Vas and the Nrs. disability sec-
ondary to LBP should be measured with a specific scale, 
including the oswestry disability index and the roland 
Morris disability Questionnaire.33
detailed evaluation of patients with fbss is key to 
obtain valuable information on the etiology of persis-
tent or recurrent pain, the patient’s psychosocial status, 
comorbidities, and previous interventions and/or thera-
peutic approaches. Red and yellow flags should be care-
fully looked for, and neuroimaging, electrodiagnostic 
and/or laboratory tests performed as needed.35
OP
op intensity can be measured with generic scales 
such as the Vas and the Nrs. there are a number of 
scales that evaluate functioning and disability in pa-
tients affected by op. some scales (e.g., the pain dis-
ability Index) are generic, while others are specific for 
a single type of op (e.g., the Neck disability index). 
rating scales that have been translated and validated in 
the patient’s language should be used.36, 37 radiologic 
and laboratory examinations are helpful for exploring 
the cause of op and to guide pharmacological and non-
pharmacological treatment decisions.
CPP, including endometriosis, pelvic inflammatory dis-
ease, painful pelvic adhesion syndrome, interstitial cys-
titis, irritable bowel disease, proctosigmoiditis, ulcer-
ative colitis, colon diverticulosis, tumors, pelvic Mps, 
and pudendal neuropathy. cpp represents an umbrella 
term that encompasses nociceptive, neuropathic, and 
visceral pain, diseases associated with pelvic muscle 
hyperactivity, and complex conditions such as restless 
genitalia syndrome.26-28 the main terms and syndromes 
associated with cpp are reported in table i. coexistent 
fM and psychological changes secondary to cpp may 
contribute to cpp and its burden.
Recommendation 7.1.1. the international headache 
society diagnostic guidelines should be used for clas-
sifying headache and craniofacial pain subtypes (b).
Recommendation 7.1.2. osteoarticular pain and low 
back pain should be assessed in patients with stroke, 
parkinson’s disease, spinal cord injury, and multiple 
sclerosis (Gpp).
Recommendation 7.1.3. Better classification of chronic 
pelvic pain, which encompasses nociceptive, neuropath-
ic, and visceral pain, as well as pelvic muscle hyperactiv-
ity and complex conditions, is recommended (Gpp).
Question 7.2. Are there methods or standardized criteria 
for the assessment of pain in headache, craniofacial 
pain, low back pain, osteoarticular pain, myofascial 
pain, fibromyalgia, and chronic pelvic pain?
HeadacHe and cFP
the visual analogue scale (Vas), the numerical rating 
scale (Nrs), and their variants can be used for grading 
pain intensity in headache and cfp. the Migraine dis-
ability assessment score (Midas) has been proposed 
and validated as a simple self-administered questionnaire 
to quantify the degree of disability due to headache.29 
the clinical usefulness of Midas is limited by the lack 
of items investigating other conditions, such as anxiety 
and mood disorders that should be evaluated in patients 
with pain. headache patients are usually asked to keep 
a monthly headache diary for reporting pain intensity 
(0=no pain, 1=mild, 2=moderate, 3=severe), headache 
frequency and duration, aura, symptoms associated with 
headache, as well as drug intake and efficacy, the last be-
ing indirectly measured by pain relief or cessation.30-32
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Recommendation 7.2.3. Red flags indicating the pos-
sible presence of a severe disease, and yellow flags sig-
naling a risk for pain chronicization should be assessed 
in patients with low back pain and failed back surgery 
syndrome (b).
Recommendation 7.2.4. the 2010 american college 
of rheumatology criteria are recommended for the di-
agnosis of fibromyalgia (B).
Question 7.3. What is the impact of headache, cranio-
facial pain, low back pain, osteoarticular pain, myo-
fascial pain, fibromyalgia, and chronic pelvic pain on 
neurorehabilitation?
HeadacHe and cFP
We found no useful data on this issue.
LBP and FBSS
Chronic LBP has a significant socioeconomic im-
pact in terms of lost productivity, prolonged disability, 
and increased costs for medical care or indemnity pay-
ment.43 among active workers aged 45-65 years, lbp is 
one of the most frequent causes of job loss, diminished 
Qol and mental well-being.
patients with fbss experience higher levels of pain, 
have higher rates of absence from work, and show 
lower Qol scores when compared with patients suffer-
ing from other chronic pain conditions.12, 44 the annual 
cost in u.s. dollars for medical treatment of fbss is 
estimated at $18,883 per patient in the united states.35 
Based on these figures, strategies to prevent and satis-
factorily manage fbss are recommended.
OP
op is a leading cause of disability and diminished 
Qol and a common complaint in patients with neuro-
logical conditions such as stroke.44, 45 however, reliable 
data on the impact of op on neurorehabilitation proce-
dures are scant because of contrasting evidence and the 
presence of mixed pain conditions.13, 14, 46
MPS and FM
to the best of our knowledge, there is no evidence on 
the impact of Mps or fM on neurorehabilitation proce-
MPS and FM
The diagnosis of MPS is based on the identification of 
trigger points in the taut band by palpation of sensitive 
nodules to elicit local twitch response and specific patterns 
of pain associated with each trigger point.1 the american 
college of rheumatology (acr) 2010 preliminary diag-
nostic criteria for diagnosing fM consists of two scales, 
the Widespread pain index (part 1) that assesses pain at 19 
sites depicted on a body diagram, and the symptom se-
verity scale (part 2).38 With the 2011 modification of the 
acr 2010 criteria, the physician’s estimate of the extent 
of somatic symptoms was substituted by the sum of three 
specific self-reported symptoms.39
cPP
accurate clinical history taking is important in cpp 
because approximately 30% of women with cpp de-
velop this condition following pelvic inflammatory dis-
ease, probably as a result of permanent abnormalities 
of the uterus, fallopian tube, and/or ovaries.27, 40 pain 
intensity should be rated with the Vas or Nrs, pain 
distribution should be accurately assessed, and infor-
mation on sexual functioning, disability, and previous 
failed treatments collected.27 a recent study suggested 
that approximately one third of cpp patients may suf-
fer from neuropathic pain,41 according to a neuropathic 
pain screening tool.13 Neurological examination should 
be performed whenever possible. potentially treatable 
causes of cpp should always be sought and identi-
fied, and instrumental examination, such as transvaginal 
ultrasonography or pelvic magnetic resonance imaging 
(Mri) should be performed accordingly.27, 42 Electrodi-
agnostic assessment of the pelvic floor is recommended 
when a neuropathic cause of cpp is suspected.13
Recommendation 7.2.1. the visual analogue scale and 
the numerical rating scale should be used for the assess-
ment of pain intensity in headache, craniofacial pain, 
low back pain, osteoarticular pain, myofascial pain, fi-
bromyalgia, and chronic pelvic pain (b).
Recommendation 7.2.2. Generic or specific disability 
scales should be used to explore the impact of headache 
pain, craniofacial pain, low back pain (b), osteoarticu-
lar pain, myofascial pain, fibromyalgia, and chronic pel-
vic pain (Gpp).
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data. Mechanical overload at the lumbar level and other 
occupational risk factors (e.g., stress, rotation or sudden 
movements of the spinal column, whole-body vibration) 
appear to be a prognostic factor for lbp chronicity. re-
duction or avoidance of these factors could prevent lbp 
recurrence after an acute attack. in contrast, prolonged 
sitting or sedentary lifestyle does not seem to consistently 
predict lbp.53 as mentioned above (see question 7.2), 
yellow flags should always be assessed in LBP patients.34
risk factors for fbss include psychological and so-
cio-economic variables, repeated surgery, inadequate 
surgical technique or approach to the wrong vertebral 
level (2.1-2.7% of cases), surgical complications (e.g., 
infection, hematoma, lbp recurrence after discectomy 
(15% of cases), epidural fibrosis (20-36% of cases), and 
myofascial pain resulting from prolonged dissection of 
the paraspinal muscles during surgery.35 it should be not-
ed that the success rate of the first spinal surgical proce-
dure is approximately 50%, but it falls to 30%, 15%, and 
5% after the second to fourth operations, respectively.35
MPS and FM
both mechanical (i.e., structural, postural and ergo-
nomic) and non-mechanical (i.e., medical) causes may 
exacerbate MPS and FM and negatively influence pain 
treatment. in particular, medical factors that contribute 
to pain persistence include nutritional deficits (e.g., vi-
tamin b12, vitamin d, iron), hormonal dysfunctions 
(e.g., thyroid diseases, growth hormone deficiency), 
and infections (e.g., enterovirus, lyme disease, recur-
rent candida albicans).54 lipid and lipoprotein levels, 
salivary cortisol, and anxiety levels were also found to 
be associated with Mps.55 other risk factors for fM are 
female sex and psychological distress.56
cPP
depression, anxiety, low sociocultural status and past 
history of physical or sexual abuse have been reported 
as risk factors for cpp, but the data on this topic are 
scanty.40, 57
Recommendation 7.4.1. studies on risk factors and 
predictors for headache, craniofacial pain, low back 
pain, osteoarticular pain, myofascial pain, fibromyal-
gia, and chronic pelvic pain in neurorehabilitation are 
recommended (Gpp).
dures. in these conditions, however, pain intensity may 
be related to health status and mediate the association 
between physical activity and daily functioning.47, 48
cPP
CPP has a significant impact on daily functioning, 
work, and Qol. cpp patients often present with psy-
chological comorbidities, sleep disorders, and fatigue. 
in a 1992 uK survey, the costs related to cpp were es-
timated to be approximately £180 million.49 data on the 
burden of cpp on neurorehabilitation are lacking.
Recommendation 7.3.1. studies on the impact of head-
ache, craniofacial pain, low back pain, osteoarticular 
pain, myofascial pain, fibromyalgia, and chronic pelvic 
pain on neurorehabilitation are recommended (Gpp).
Question 7.4. Are there predictive factors for the de-
velopment of headache, craniofacial pain, low back 
pain, osteoarticular pain, myofascial pain, FM, and 
chronic pelvic pain?
HeadacHe and cFP
the literature on this issue is very scant. headache is 
reported in 10-13% of stroke patients, but no risk fac-
tors have been identified.50, 51 preexisting migraine may 
reappear after cognitive function recovery in patients 
with severe brain injury, but the mechanisms underly-
ing this phenomenon are unclear.52
LBP and FBSS
demographic risk factors for the onset and the clini-
cal course of lbp include age, gender, body-mass index 
(bMi), and educational level. the incidence of lbp is 
highest in the third decade of life and its prevalence in-
creases with age up to 60-65 years. chronic lbp is re-
ported to be more frequent in women, but the data are 
contradictory.43 a stronger correlation between lbp and 
a high bMi (>30) has been reported in women than in 
men. low educational levels, longer duration of each 
episode, and worse outcome have all been linked to the 
high prevalence of lbp. the few studies that have ex-
plored the correlation between genetic factors and lum-
bar disc degeneration have reported only preliminary 
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servative treatments fail.70 a meta-analysis showed that 
psychosocial interventions do appear not to be superior to 
usual treatment for myofascial tMd pain.71 acupuncture 
was found to have short-term efficacy in relieving TMD 
pain, but the results were not conclusive due to the limited 
number of patients evaluated.72
for the pharmacological treatment of trigeminal neu-
ralgia (tN), we recommend reference to the European 
federation of Neurological societies guidelines.73 rcts 
offer insufficient evidence on non-antiepileptic drugs in 
tN.74 for refractory tN, botulinum neurotoxin type a 
(boNt-a) may represent an effective treatment, with re-
sponse rates up to 85%, similar to those achieved with 
carbamazepine/oxcarbamazepine, a reduction in mean 
duration of pain of 105 days,75 level b evidence for tN,76 
and the additional indication of hemifacial spasm.77
other topical treatments, which include the 5% lido-
caine patch and the 8% capsaicin patch, play a role in 
relieving neuropathic pain,78 but there is no evidence to 
date for their use in orofacial pain and tN.
there is no conclusive evidence for the role of local 
drug infiltration or arthrocentesis associated with injection 
of low- or high-molecular-weight hyaluronic acid or corti-
sone in osteoarthritic tMd.79 the quality of the evidence 
on interventional procedures in tN is low. a prospective 
non-randomized study showed that retrogasserian rhizo-
lysis with glycerol and percutaneous radiofrequency ther-
mocoagulation can induce a moderate reduction in pain in 
tN.80 the combination of continuous and pulsed radio-
frequency produced better results than continuous radio-
frequency alone, reduced the duration of treatment, and 
resulted in long-lasting effects.81
the features of glossopharyngeal neuralgia (GN) pain 
are similar to those of tN. however, pharmacological 
treatments for tN are largely ineffective for GN and 
invasive procedures are frequently required.82 finally, 
there are no conclusive data regarding facial neuralgia 
(i.e., facial pain other than typical tN) and bell’s palsy.
LBP and FBSS
the treatment of acute and chronic lbp should be well 
differentiated because they are two very different clinical 
situations. acute lbp requires mainly symptomatic treat-
ment, counseling and prevention. subacute and chronic 
LBP, because they are influenced by physical dysfunc-
tions, patient expectations, behavioral changes, and so-
Question 7.5. What is the evidence for pharmacological 
and non-pharmacological treatments of headache pain, 
craniofacial pain, low back pain, osteoarticular pain, 
myofascial pain, fibromyalgia, and chronic pelvic pain?
HeadacHe and cFP
the italian society for the study of headache (sisc) 
provides pharmacological guidelines for ph.31 the re-
sults from our search for more recent evidence show 
that the sisc guidelines appear up-to-date; therefore, 
we can recommend their use for guiding pharmacologi-
cal and non-pharmacological treatment of ph. recently 
published studies documented the role of meditation 
therapy,58 mindfulness-based stress reduction,59 accep-
tance and commitment therapy,60 and yoga,61 for ph, 
and neurofeedback therapy for post-stroke and post-
traumatic headache and ph.62
Non-neuropathic orofacial pain may be a manifesta-
tion of various different diseases, including periodontal, 
vascular, sinus bone alterations, cancer or temporoman-
dibular disorder (tMd),63 the last being the second most 
common cause of oral pain after odontogenic causes 
and potentially responsible for persisting/chronic pain.64 
these conditions may be accompanied by psychologi-
cal distress and reported pain of cervical origin despite 
normal laboratory or radiological findings, or accompany 
chronic pain due to other sources. to date there are no 
data supporting specific recommendations on pharmaco-
logical treatment of non-neuropathic orofacial pain. Non-
pharmacological strategies for tMd include occlusal 
splint, physical therapy, manual therapy (Mt), and acu-
puncture,65 while the evidence for orthodontic treatment is 
poor.66 Non-significant short-term improvements in pain 
intensity and joint range were reported in a randomized 
controlled trial (rct) exploring Mt and home exercise 
programs in patients with tMd.67 therapeutic exercises 
combined with conservative care appear to be effective 
in treating tMd.68 a rct involving patients with cervi-
cogenic headache and tMd showed that orofacial Mt, in 
addition to usual cervical care, has a long-term beneficial 
effect on cervical movement in comparison to the latter 
alone.69 therefore, tMd should be sought when examin-
ing patients with cervical disorders or pain. systematic re-
views on the effectiveness of physiotherapy for tMd are 
inconclusive because of the poor quality of the studies on 
this therapeutic approach. Multidisciplinary interventions 
for tMd should include surgical procedures when con-
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tients who do not respond to a combination of conservative 
treatments for severe pain, disability or spinal degenerative 
disease. arthrodesis does not appear to be any more effec-
tive than conservative approaches.10, 84 in cases of lbp and 
radiculopathy secondary to herniated disc, microdiscecto-
my is preferable over other surgical procedures because it 
is less invasive and has lower failure rates.10
a variety of physical and exercise approaches have 
been reported to reduce lbp by less than 30% and im-
prove function by less than 20% overall. the evidence 
for their effectiveness is limited owing to their inclusion 
as a part of multimodal rehabilitation programs, which 
precludes thorough evaluation of the efficacy of each 
therapeutic component.10 patients with acute lbp are 
usually advised to be active, but the relationship between 
physical activity and disability in acute lbp is weak.85 
Educational booklets, back school programs, and behav-
ioral therapy may be useful to ameliorate Qol, reduce 
the risk of lbp recurrence, and improve mood in acute, 
subacute, and chronic lbp, but the evidence is scanty and 
there are no data on patient selection criteria that predict 
who might be best responders to such treatments.33 data 
on spinal manipulations and recommendations from dif-
ferent guidelines are contrasting. transcutaneous electri-
cal nerve stimulation (tENs) is often used in the treat-
ment of chronic lbp, but because the evidence for its 
efficacy is very low, TENS is not recommended for the 
treatment of lbp.78, 86 other physical therapies include 
therapeutic ultrasound and laser therapy.87 one system-
atic review demonstrated that acupuncture, a popular 
complementary treatment, may have a favorable effect 
on self-reported pain and functional limitations in lbp 
patients, but the results need to be interpreted with cau-
tion because of the heterogeneous study population and 
low methodological quality.88
there are few rcts and guidelines on the treatment 
of fbss, a chronic condition that requires individualized 
multidisciplinary treatment to recover function, improve 
Qol, and develop coping strategies to pain.35 com-
monly prescribed drugs for fbss include paracetamol, 
Nsaids, coX-2 inhibitors, tramadol, opioids, and other 
drugs for neuropathic pain (i.e., gabapentin, antidepres-
sants) despite the lack of RCTs testing their efficacy in 
this condition.35 physical exercise and rehabilitation are 
commonly prescribed for fbss patients, who often de-
velop deconditioning with muscular weakness and spi-
nal instability, but the evidence for their effectiveness 
cial interactions, require a multimodal multidisciplinary 
approach based on a biopsychosocial model of disease 
where rehabilitation can play a major role. chronic lbp 
treatment should be aimed at reducing pain and disability 
and improving Qol. though many treatment options are 
available for LBP, their efficacy is often very limited and 
the quality of evidence is low.10
The following two paragraphs briefly summarize the 
main pharmacological options for lbp. paracetamol 
should be considered as first-line treatment for LBP due 
to its good side-effects profile; however, a recent review 
reported no statistically significant difference between 
paracetamol and other drugs.10 a systematic review dem-
onstrated the short-term efficacy of nonsteroidal anti-in-
flammatory drugs (NSAIDs) with no difference between 
single active principles in this drug group;83 hence, they 
should be used as second-line treatment in acute and 
chronic lbp. tramadol is slightly better than placebo for 
lbp and related disability; its effectiveness is comparable 
to that of Nsaids and weak opioids,10 making it a third-
line therapeutic option in lbp. the use of opioids in lbp 
is controversial because of their limited efficacy in com-
parison to placebo or non-opioid analgesics.78 opioids 
should be considered only as a short-term third-level op-
tion in patients with severe and disabling pain unrespon-
sive to paracetamol, Nsaids, and tramadol, or in patients 
with moderate-to-severe pain but at high risk for Nsaid 
complications.78 long-acting opioids can be considered in 
patients with chronic lbp, while short-acting opioids are 
preferable in acute lbp.83 tricyclic antidepressants were 
found to be slightly more effective or ineffective versus 
placebo. While they are not recommended as first-line 
treatment for chronic lbp,10 they can be considered in 
refractory patients. RCTs demonstrated no beneficial ef-
fect of systemic corticosteroids versus placebo in patients 
with lbp, either associated or not with radicular pain;83 
therefore, treatment with these drugs is not recommended.
there is no evidence that local anesthetic injection, 
with or without corticosteroids, chemical irritants, in-
tramuscular boNt-a injection, intradiscal or epidural 
injection of steroids or proteolytic enzymes may be ef-
fective in lbp.10 recent guidelines on interventional 
procedures for neuropathic pain do, however, give weak 
recommendation for the use of steroid injections for ra-
diculopathy, which may coexist with lbp.78
Despite its low evidence of efficacy, surgical or percuta-
neous vertebral arthrodesis may be considered in lbp pa-
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tropisetron, nabilone, sodium oxybate, central muscle re-
laxants (i.e., cyclobenzaprine, carisoprodol, tizanidine, 
methocarbamol, and metaxalone) alone or in combina-
tion with analgesics (i.e., paracetamol, Nsaids).92-94 a 
very recent meta-analysis on the pharmacological treat-
ment of fM explored as outcome measures not only 
pain, but also an extensive list of symptoms that includ-
ed pain, tenderness, fatigue, multidimensional function, 
sleep disturbances, depression, cognitive dysfunction, 
stiffness, and anxiety. While treatment with most phar-
macological classes resulted in a reduction in pain and/
or fatigue, very few have demonstrated improvement 
in other domains, and sNris and Nris were the only 
drug classes possibly associated with overall treatment 
response.95
there is a wide variety of non-pharmacological 
approaches to treating Mps and fM pain: ergonom-
ics, traction, mechanical massage, fascial manipula-
tion, whole-body vibration, chiropractic management, 
craniosacral therapy, aerobic exercise, stretching ex-
ercise, biofeedback, cognitive-behavioral therapy 
(cbt), acupuncture, dry needling, spa therapy, bal-
neotherapy, hypnotherapy, yoga, ischemic acupres-
sure or shiatsu, hot and cold therapies (i.e. cold and 
hot packs, Whirlpool and Jacuzzi jet massaging ther-
apy, Waon soothing warmth therapy), extracorporeal 
shock wave therapy, ultrasound therapy, Ga-al-as 
laser therapy, electrotherapy (tENs, interferential 
therapy, frEMs therapy) and phonophoresis.92, 96-101 
A network meta-analysis showed that the benefits of 
pharmacological treatments in fM are of question-
able clinical relevance, the evidence for benefits of 
non-pharmacological interventions is limited, and that 
the combination of pregabalin or sNris, as pharma-
cological interventions, and multicomponent therapy, 
aerobic exercise and cbt, as non-pharmacological 
interventions, seems most promising for the manage-
ment of fM.102 it is suggested that a multidisciplinary 
approach to fM should include education about the 
nature of disorder, counseling regarding the role of ex-
ercise, cbt, and pharmacological therapy as guided 
by the predominant symptoms that accompany pain 
(e.g., sNris for comorbid depression or fatigue, pre-
gabalin or gabapentin for comorbid anxiety or sleep 
disturbances) and the combined use of several classes 
drugs, including Nsaids and paracetamol, while the 
use of opioids is often discouraged.103
is lacking. behavioral therapy, because of the primary 
role psychological factors play in the chronicization of 
pain in fbss, may be helpful in some cases. While in-
vasive procedures including surgery are used for diag-
nostic and therapeutic purposes, the risk of exacerbating 
pain needs to be adequately weighed along with other 
factors. based on the evidence from moderate-to-high 
quality rcts, spinal cord stimulation (scs) should be 
considered in fbss and lbp refractory to conservative 
management.78, 89 high frequency, burst, and adaptive 
stimulation are new scs modalities that seem to be more 
effective than conventional scs, but their role in fbss 
has not been consistently explored.78
 OP
a thorough review of currently available pharmaco-
logical and non-pharmacological therapies for op and 
their evidence levels is beyond the scope of this article. 
pharmacological and non-pharmacological treatment of 
nociceptive pain, including opioids, invasive procedures, 
physical therapy, and psychotherapies have been exam-
ined in detail elsewhere. 78, 90 patients with neurological 
conditions may experience secondary op (e.g., shoulder 
pain after stroke is common). detailed recommendations 
for the treatment of op associated with spasticity, stroke, 
multiple sclerosis, spinal cord injury, and cerebral palsy, 
parkinson’s disease, motor neuron disease, dementia, 
severe acquired brain injury, disorders of consciousness, 
(neuro) oncology and neuroinfectious diseases are re-
ported in other iccpN articles.24, 91
MPS and FM
pharmacological therapies proposed for Mps include 
trigger point injections, spray and stretch with vapo-
coolants, topical analgesics, glucosamine and methyl-
sulfomethane, Nsaids, and boNt-a injections;1 how-
ever, no conclusions on the efficacy of the majority of 
these treatments can be drawn due to the low quality 
of studies. Numerous drugs are indicated for the treat-
ment of pain in fM, including pregabalin, gabapentin, 
anticonvulsants, selective serotonin reuptake inhibitors, 
serotonin norepinephrine reuptake inhibitors (sNris), 
norepinephrine reuptake inhibitors (Nris), tricyclic an-
tidepressants, dopaminergic agents, tramadol, opioids, 
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Recommendation 7.5.1. We recommend reference to 
the italian society for the study of headache guidelines 
for the pharmacological and non-pharmacological treat-
ment of primary headaches (a).
Recommendation 7.5.2. Non-pharmacological strate-
gies including manual therapy (d) and multidisciplinary 
approaches (Gpp) should be considered for temporo-
mandibular disorder.
Recommendation 7.5.3. We recommend reference 
to the European federation of Neurological societies 
guidelines for the pharmacological treatment of trigem-
inal neuralgia (a).
Recommendation 7.5.4. botulinum neurotoxin type a 
injection is effective for the treatment of idiopathic tri-
geminal neuralgia and hemifacial spasm (b).
Recommendation 7.5.5. a multidisciplinary rehabilita-
tion approach based on the biopsychosocial model of 
disease is recommended for the treatment of subacute 
and chronic low back pain and failed back surgery syn-
drome (Gpp).
Recommendation 7.5.6. for the pharmacological treat-
ment of low back pain, paracetamol should be consid-
ered as first-line, nonsteroidal anti-inflammatory drugs 
as second-line, and tramadol and opioids as third-line 
treatment (a). the drug dosage should be tailored to each 
patient, and the side-effects profile considered (GPP). 
short-use of opioids is recommended (Gpp). tricyclic 
antidepressants and systemic corticosteroids should not 
be used in the treatment of chronic low back pain (b).
Recommendation 7.5.7. among invasive procedures, 
steroid injections can be considered for radiculopathy 
coexisting with low back pain (b), microdiscectomy is 
preferable over other surgical procedures in the treat-
ment of low back pain and radiculopathy secondary to 
herniated disc (c). other surgical procedures can be 
considered only in patients who do not respond to a 
combination of conservative treatments and have severe 
chronic pain and disability (Gpp).
Recommendation 7.5.8. rehabilitation approaches 
have limited efficacy on low back pain and related dis-
ability; however, they should be considered in the mul-
tidisciplinary treatment of low back pain because of the 
absence of side effects (b). transcutaneous electrical 
stimulation and other physical therapies are not recom-
mended for low back pain (a).
cPP
analgesics and drugs for neuropathic pain are com-
monly considered potential treatments for cpp, but 
pharmacological treatment guidelines for nociceptive 
and neuropathic pain are difficult to translate to this con-
dition because few studies have investigated the use of 
these drugs in cpp.78 for example, pregabalin, which is 
first-line treatment for neuropathic pain and demonstrated 
by rcts as being effective for pain relief, was ineffec-
tive and associated with adverse effects in the only rct 
involving men with chronic prostatitis/cpp.104 cpp is a 
complex condition that comprises a heterogeneous array 
of clinical conditions with largely unknown pathophysi-
ology (table i). rcts evaluating the use of antibiotics, 
α-blockers, anti-inflammatory and immune-modulating 
substances, bioflavonoids, hormonal agents, phytothera-
peutics, neuromodulatory drugs, topical local anesthetics, 
agents that modify bladder function, pelvic floor physical 
treatment, muscle biofeedback, tENs, percutaneous tib-
ial nerve stimulation, cbt, and acupuncture all failed to 
achieve a clear therapeutic benefit after a single treatment 
in cpp. the best evidence-based management strongly 
suggests a multimodal therapeutic approach that address-
es the individual clinical phenotypic profile.27, 105 invasive 
procedures including bladder instillation therapy, periph-
eral nerve blocks, sacral neuromodulation, and other sur-
gical procedures may be an effective choice, but because 
the overall evidence is limited, such interventions should 
be managed by a pelvic pain therapist within a framework 
of different therapeutic options.106, 107 Pelvic floor muscu-
lature contracture can contribute to cpp. since injection 
of boNt-a acts on muscle hyperactivity and inhibits the 
release of peripheral neurotransmitters and inflammatory 
mediators from sensory nerves, it may be a promising 
strategy for this condition.108 preliminary studies show 
that BoNT-A injection in the pelvic floor muscle improves 
dyspareunia and decreases pelvic floor pressure, and that 
intravesical BoNT-A injection is useful in inflammatory 
bladder diseases, such as chemical cystitis, radiation cys-
titis, and ketamine-related cystitis.109 further research into 
the treatment of cpp is needed. by combining the data 
from rcts with biomarker, genomic, and imaging stud-
ies, coupled with epidemiologic and symptom-based as-
sessments, researchers can maximize the ability to probe 
the etiology and pathogenesis of this disease, and identify 
effective treatment.110
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a, et al.; italian consensus conference on pain in Neurorehabilitation 
(iccpN). assessing and treating pain associated with stroke, multiple 
sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence 
and recommendations from the italian consensus conference on pain 
in Neurorehabilitation. Eur J phys rehabil Med 2016;52:827-40.
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Recommendation 7.5.9. Acupuncture has a beneficial 
effect on pain and functional limitations and should be 
considered in the multidisciplinary treatment of low 
back pain, but much work is still needed to improve the 
quality of studies on this topic (b).
Recommendation 7.5.10. spinal cord stimulation 
should be considered for failed back surgery syndrome 
not responsive to less invasive treatments (b). further 
research is recommended for this condition (Gpp).
Recommendation 7.5.11. botulinum neurotoxin type a 
injection can be considered for the treatment of myofas-
cial pain syndrome in neck and head muscles (b).
Recommendation 7.5.12. a multidisciplinary approach, 
which includes pharmacological treatment with prega-
balin/gabapentin, and/or serotonin norepinephrine reup-
take inhibitors, and non-pharmacological strategies, such 
as aerobic exercise and cognitive-behavioral therapy, 
is recommended for the treatment of fibromyalgia (A). 
Other treatments for fibromyalgia that can be considered 
include tramadol, fluoxetine, massage therapy, and laser 
therapy (b), acupuncture and trigger point injection (c).
Recommendation 7.5.13. a multidisciplinary approach 
addressing the individual clinical phenotypic profile is rec-
ommended in the treatment of chronic pelvic pain (Gpp).
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